1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Antiretroviral Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Multi-Class Drugs Combination
        1.2.3 NRTI
        1.2.4 NNRTI
        1.2.5 Protease Inhibitors
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Antiretroviral Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Pharmaceutical Companies
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Antiretroviral Drug Market Perspective (2017-2028)
    2.2 Antiretroviral Drug Growth Trends by Region
        2.2.1 Antiretroviral Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Antiretroviral Drug Historic Market Size by Region (2017-2022)
        2.2.3 Antiretroviral Drug Forecasted Market Size by Region (2023-2028)
    2.3 Antiretroviral Drug Market Dynamics
        2.3.1 Antiretroviral Drug Industry Trends
        2.3.2 Antiretroviral Drug Market Drivers
        2.3.3 Antiretroviral Drug Market Challenges
        2.3.4 Antiretroviral Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Antiretroviral Drug Players by Revenue
        3.1.1 Global Top Antiretroviral Drug Players by Revenue (2017-2022)
        3.1.2 Global Antiretroviral Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Antiretroviral Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Antiretroviral Drug Revenue
    3.4 Global Antiretroviral Drug Market Concentration Ratio
        3.4.1 Global Antiretroviral Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Antiretroviral Drug Revenue in 2021
    3.5 Antiretroviral Drug Key Players Head office and Area Served
    3.6 Key Players Antiretroviral Drug Product Solution and Service
    3.7 Date of Enter into Antiretroviral Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Antiretroviral Drug Breakdown Data by Type
    4.1 Global Antiretroviral Drug Historic Market Size by Type (2017-2022)
    4.2 Global Antiretroviral Drug Forecasted Market Size by Type (2023-2028)
5 Antiretroviral Drug Breakdown Data by Application
    5.1 Global Antiretroviral Drug Historic Market Size by Application (2017-2022)
    5.2 Global Antiretroviral Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Antiretroviral Drug Market Size (2017-2028)
    6.2 North America Antiretroviral Drug Market Size by Type
        6.2.1 North America Antiretroviral Drug Market Size by Type (2017-2022)
        6.2.2 North America Antiretroviral Drug Market Size by Type (2023-2028)
        6.2.3 North America Antiretroviral Drug Market Share by Type (2017-2028)
    6.3 North America Antiretroviral Drug Market Size by Application
        6.3.1 North America Antiretroviral Drug Market Size by Application (2017-2022)
        6.3.2 North America Antiretroviral Drug Market Size by Application (2023-2028)
        6.3.3 North America Antiretroviral Drug Market Share by Application (2017-2028)
    6.4 North America Antiretroviral Drug Market Size by Country
        6.4.1 North America Antiretroviral Drug Market Size by Country (2017-2022)
        6.4.2 North America Antiretroviral Drug Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Antiretroviral Drug Market Size (2017-2028)
    7.2 Europe Antiretroviral Drug Market Size by Type
        7.2.1 Europe Antiretroviral Drug Market Size by Type (2017-2022)
        7.2.2 Europe Antiretroviral Drug Market Size by Type (2023-2028)
        7.2.3 Europe Antiretroviral Drug Market Share by Type (2017-2028)
    7.3 Europe Antiretroviral Drug Market Size by Application
        7.3.1 Europe Antiretroviral Drug Market Size by Application (2017-2022)
        7.3.2 Europe Antiretroviral Drug Market Size by Application (2023-2028)
        7.3.3 Europe Antiretroviral Drug Market Share by Application (2017-2028)
    7.4 Europe Antiretroviral Drug Market Size by Country
        7.4.1 Europe Antiretroviral Drug Market Size by Country (2017-2022)
        7.4.2 Europe Antiretroviral Drug Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Antiretroviral Drug Market Size (2017-2028)
    8.2 Asia-Pacific Antiretroviral Drug Market Size by Type
        8.2.1 Asia-Pacific Antiretroviral Drug Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Antiretroviral Drug Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Antiretroviral Drug Market Share by Type (2017-2028)
    8.3 Asia-Pacific Antiretroviral Drug Market Size by Application
        8.3.1 Asia-Pacific Antiretroviral Drug Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Antiretroviral Drug Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Antiretroviral Drug Market Share by Application (2017-2028)
    8.4 Asia-Pacific Antiretroviral Drug Market Size by Region
        8.4.1 Asia-Pacific Antiretroviral Drug Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Antiretroviral Drug Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Antiretroviral Drug Market Size (2017-2028)
    9.2 Latin America Antiretroviral Drug Market Size by Type
        9.2.1 Latin America Antiretroviral Drug Market Size by Type (2017-2022)
        9.2.2 Latin America Antiretroviral Drug Market Size by Type (2023-2028)
        9.2.3 Latin America Antiretroviral Drug Market Share by Type (2017-2028)
    9.3 Latin America Antiretroviral Drug Market Size by Application
        9.3.1 Latin America Antiretroviral Drug Market Size by Application (2017-2022)
        9.3.2 Latin America Antiretroviral Drug Market Size by Application (2023-2028)
        9.3.3 Latin America Antiretroviral Drug Market Share by Application (2017-2028)
    9.4 Latin America Antiretroviral Drug Market Size by Country
        9.4.1 Latin America Antiretroviral Drug Market Size by Country (2017-2022)
        9.4.2 Latin America Antiretroviral Drug Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Antiretroviral Drug Market Size (2017-2028)
    10.2 Middle East & Africa Antiretroviral Drug Market Size by Type
        10.2.1 Middle East & Africa Antiretroviral Drug Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Antiretroviral Drug Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Antiretroviral Drug Market Share by Type (2017-2028)
    10.3 Middle East & Africa Antiretroviral Drug Market Size by Application
        10.3.1 Middle East & Africa Antiretroviral Drug Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Antiretroviral Drug Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Antiretroviral Drug Market Share by Application (2017-2028)
    10.4 Middle East & Africa Antiretroviral Drug Market Size by Country
        10.4.1 Middle East & Africa Antiretroviral Drug Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Antiretroviral Drug Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Gilead Sciences
        11.1.1 Gilead Sciences Company Details
        11.1.2 Gilead Sciences Business Overview
        11.1.3 Gilead Sciences Antiretroviral Drug Introduction
        11.1.4 Gilead Sciences Revenue in Antiretroviral Drug Business (2017-2022)
        11.1.5 Gilead Sciences Recent Developments
    11.2 ViiV Healthcare
        11.2.1 ViiV Healthcare Company Details
        11.2.2 ViiV Healthcare Business Overview
        11.2.3 ViiV Healthcare Antiretroviral Drug Introduction
        11.2.4 ViiV Healthcare Revenue in Antiretroviral Drug Business (2017-2022)
        11.2.5 ViiV Healthcare Recent Developments
    11.3 Bristol-Myer Squibb
        11.3.1 Bristol-Myer Squibb Company Details
        11.3.2 Bristol-Myer Squibb Business Overview
        11.3.3 Bristol-Myer Squibb Antiretroviral Drug Introduction
        11.3.4 Bristol-Myer Squibb Revenue in Antiretroviral Drug Business (2017-2022)
        11.3.5 Bristol-Myer Squibb Recent Developments
    11.4 AbbVie
        11.4.1 AbbVie Company Details
        11.4.2 AbbVie Business Overview
        11.4.3 AbbVie Antiretroviral Drug Introduction
        11.4.4 AbbVie Revenue in Antiretroviral Drug Business (2017-2022)
        11.4.5 AbbVie Recent Developments
    11.5 Boehringer-Ingelheim
        11.5.1 Boehringer-Ingelheim Company Details
        11.5.2 Boehringer-Ingelheim Business Overview
        11.5.3 Boehringer-Ingelheim Antiretroviral Drug Introduction
        11.5.4 Boehringer-Ingelheim Revenue in Antiretroviral Drug Business (2017-2022)
        11.5.5 Boehringer-Ingelheim Recent Developments
    11.6 Johnson and Johnson
        11.6.1 Johnson and Johnson Company Details
        11.6.2 Johnson and Johnson Business Overview
        11.6.3 Johnson and Johnson Antiretroviral Drug Introduction
        11.6.4 Johnson and Johnson Revenue in Antiretroviral Drug Business (2017-2022)
        11.6.5 Johnson and Johnson Recent Developments
    11.7 Merck
        11.7.1 Merck Company Details
        11.7.2 Merck Business Overview
        11.7.3 Merck Antiretroviral Drug Introduction
        11.7.4 Merck Revenue in Antiretroviral Drug Business (2017-2022)
        11.7.5 Merck Recent Developments
    11.8 CIPLA
        11.8.1 CIPLA Company Details
        11.8.2 CIPLA Business Overview
        11.8.3 CIPLA Antiretroviral Drug Introduction
        11.8.4 CIPLA Revenue in Antiretroviral Drug Business (2017-2022)
        11.8.5 CIPLA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Antiretroviral Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Multi-Class Drugs Combination
    Table 3. Key Players of NRTI
    Table 4. Key Players of NNRTI
    Table 5. Key Players of Protease Inhibitors
    Table 6. Key Players of Other
    Table 7. Global Antiretroviral Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Antiretroviral Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Antiretroviral Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Antiretroviral Drug Market Share by Region (2017-2022)
    Table 11. Global Antiretroviral Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Antiretroviral Drug Market Share by Region (2023-2028)
    Table 13. Antiretroviral Drug Market Trends
    Table 14. Antiretroviral Drug Market Drivers
    Table 15. Antiretroviral Drug Market Challenges
    Table 16. Antiretroviral Drug Market Restraints
    Table 17. Global Antiretroviral Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Antiretroviral Drug Revenue Share by Players (2017-2022)
    Table 19. Global Top Antiretroviral Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiretroviral Drug as of 2021)
    Table 20. Ranking of Global Top Antiretroviral Drug Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Antiretroviral Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Antiretroviral Drug Product Solution and Service
    Table 24. Date of Enter into Antiretroviral Drug Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Antiretroviral Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Antiretroviral Drug Revenue Market Share by Type (2017-2022)
    Table 28. Global Antiretroviral Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Antiretroviral Drug Revenue Market Share by Type (2023-2028)
    Table 30. Global Antiretroviral Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Antiretroviral Drug Revenue Share by Application (2017-2022)
    Table 32. Global Antiretroviral Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Antiretroviral Drug Revenue Share by Application (2023-2028)
    Table 34. North America Antiretroviral Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Antiretroviral Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Antiretroviral Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Antiretroviral Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Antiretroviral Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Antiretroviral Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Antiretroviral Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Antiretroviral Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Antiretroviral Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Antiretroviral Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Antiretroviral Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Antiretroviral Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Antiretroviral Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Antiretroviral Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Antiretroviral Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Antiretroviral Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Antiretroviral Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Antiretroviral Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Antiretroviral Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Antiretroviral Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Antiretroviral Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Antiretroviral Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Antiretroviral Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Antiretroviral Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Antiretroviral Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Antiretroviral Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Antiretroviral Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Antiretroviral Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Antiretroviral Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Antiretroviral Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Gilead Sciences Company Details
    Table 65. Gilead Sciences Business Overview
    Table 66. Gilead Sciences Antiretroviral Drug Product
    Table 67. Gilead Sciences Revenue in Antiretroviral Drug Business (2017-2022) & (US$ Million)
    Table 68. Gilead Sciences Recent Developments
    Table 69. ViiV Healthcare Company Details
    Table 70. ViiV Healthcare Business Overview
    Table 71. ViiV Healthcare Antiretroviral Drug Product
    Table 72. ViiV Healthcare Revenue in Antiretroviral Drug Business (2017-2022) & (US$ Million)
    Table 73. ViiV Healthcare Recent Developments
    Table 74. Bristol-Myer Squibb Company Details
    Table 75. Bristol-Myer Squibb Business Overview
    Table 76. Bristol-Myer Squibb Antiretroviral Drug Product
    Table 77. Bristol-Myer Squibb Revenue in Antiretroviral Drug Business (2017-2022) & (US$ Million)
    Table 78. Bristol-Myer Squibb Recent Developments
    Table 79. AbbVie Company Details
    Table 80. AbbVie Business Overview
    Table 81. AbbVie Antiretroviral Drug Product
    Table 82. AbbVie Revenue in Antiretroviral Drug Business (2017-2022) & (US$ Million)
    Table 83. AbbVie Recent Developments
    Table 84. Boehringer-Ingelheim Company Details
    Table 85. Boehringer-Ingelheim Business Overview
    Table 86. Boehringer-Ingelheim Antiretroviral Drug Product
    Table 87. Boehringer-Ingelheim Revenue in Antiretroviral Drug Business (2017-2022) & (US$ Million)
    Table 88. Boehringer-Ingelheim Recent Developments
    Table 89. Johnson and Johnson Company Details
    Table 90. Johnson and Johnson Business Overview
    Table 91. Johnson and Johnson Antiretroviral Drug Product
    Table 92. Johnson and Johnson Revenue in Antiretroviral Drug Business (2017-2022) & (US$ Million)
    Table 93. Johnson and Johnson Recent Developments
    Table 94. Merck Company Details
    Table 95. Merck Business Overview
    Table 96. Merck Antiretroviral Drug Product
    Table 97. Merck Revenue in Antiretroviral Drug Business (2017-2022) & (US$ Million)
    Table 98. Merck Recent Developments
    Table 99. CIPLA Company Details
    Table 100. CIPLA Business Overview
    Table 101. CIPLA Antiretroviral Drug Product
    Table 102. CIPLA Revenue in Antiretroviral Drug Business (2017-2022) & (US$ Million)
    Table 103. CIPLA Recent Developments
    Table 104. Research Programs/Design for This Report
    Table 105. Key Data Information from Secondary Sources
    Table 106. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Antiretroviral Drug Market Share by Type: 2021 VS 2028
    Figure 2. Multi-Class Drugs Combination Features
    Figure 3. NRTI Features
    Figure 4. NNRTI Features
    Figure 5. Protease Inhibitors Features
    Figure 6. Other Features
    Figure 7. Global Antiretroviral Drug Market Share by Application: 2021 VS 2028
    Figure 8. Hospital Case Studies
    Figure 9. Pharmaceutical Companies Case Studies
    Figure 10. Other Case Studies
    Figure 11. Antiretroviral Drug Report Years Considered
    Figure 12. Global Antiretroviral Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Antiretroviral Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Antiretroviral Drug Market Share by Region: 2021 VS 2028
    Figure 15. Global Antiretroviral Drug Market Share by Players in 2021
    Figure 16. Global Top Antiretroviral Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiretroviral Drug as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Antiretroviral Drug Revenue in 2021
    Figure 18. North America Antiretroviral Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Antiretroviral Drug Market Size Market Share by Type (2017-2028)
    Figure 20. North America Antiretroviral Drug Market Size Market Share by Application (2017-2028)
    Figure 21. North America Antiretroviral Drug Market Size Share by Country (2017-2028)
    Figure 22. United States Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Antiretroviral Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Antiretroviral Drug Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Antiretroviral Drug Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Antiretroviral Drug Market Size Share by Country (2017-2028)
    Figure 28. Germany Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Antiretroviral Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Antiretroviral Drug Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Antiretroviral Drug Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Antiretroviral Drug Market Size Share by Region (2017-2028)
    Figure 38. China Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 44. Latin America Antiretroviral Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Antiretroviral Drug Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Antiretroviral Drug Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Antiretroviral Drug Market Size Share by Country (2017-2028)
    Figure 48. Mexico Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Antiretroviral Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Antiretroviral Drug Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Antiretroviral Drug Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Antiretroviral Drug Market Size Share by Country (2017-2028)
    Figure 54. Turkey Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Antiretroviral Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Gilead Sciences Revenue Growth Rate in Antiretroviral Drug Business (2017-2022)
    Figure 58. ViiV Healthcare Revenue Growth Rate in Antiretroviral Drug Business (2017-2022)
    Figure 59. Bristol-Myer Squibb Revenue Growth Rate in Antiretroviral Drug Business (2017-2022)
    Figure 60. AbbVie Revenue Growth Rate in Antiretroviral Drug Business (2017-2022)
    Figure 61. Boehringer-Ingelheim Revenue Growth Rate in Antiretroviral Drug Business (2017-2022)
    Figure 62. Johnson and Johnson Revenue Growth Rate in Antiretroviral Drug Business (2017-2022)
    Figure 63. Merck Revenue Growth Rate in Antiretroviral Drug Business (2017-2022)
    Figure 64. CIPLA Revenue Growth Rate in Antiretroviral Drug Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed